Besides investing in automobile and machinery, Japan can play a major role in India’s infrastructure development. Chandrajit Banerjee, Director General, CII, says CEPA is expected to give Indian pharma greater access to the Japanese market as Japan has committed to treat Indian generic-makers on a par with its own pharma industry. This article appeared in the The Financial Express on 30 November, 2013.